Skip to main content
. 2022 Jul 4;1(3):pgac071. doi: 10.1093/pnasnexus/pgac071

Table 1.

Case counts and estimated prevalences for COVID-19 and influenza coinfections from the Mayo Clinic EHR data.

(a) Case counts of coinfections from COVID-19 cohort.
Cohort Case count (%)
All COVID-19 cases (confirmed by PCR test) 197,364 (100.0%)
COVID-19 cases with lab tests for influenza within +/− 14 days 17,932 (9.1%)
COVID-19 and influenza coinfection within +/− 14 days, with diagnosis of influenza confirmed by:
- Lab test 103 (0.05%)
- ICD-10 codes + manual review 4 (0.00%)
- Clinical notes + manual review 13 (0.01%)
- Any of the above 120 (0.06%)
(b) Case counts of coinfections from influenza cohort.
Cohort Case count (%)
All influenza cases during the study period (2020 January 1 to 2022 April 2) 2,919 (100%)
COVID-19 and influenza coinfection within +/− 14 days, with diagnosis of influenza confirmed by:
- Lab test 103 (3.5%)
c) Prevalence estimates.
Description Cases/population Prevalence (95% CI)
Estimated prevalence of COVID-19 and influenza coinfections from overall COVID-19 cohort 120/197,364 0.061% [0.051%, 0.073%]
Estimated prevalence of COVID-19 and influenza coinfections from COVID-19 cohort with lab tests available 103/17,932 0.574% [0.474%, 0.696%]
Estimated prevalence of COVID-19 and influenza coinfections from overall Influenza cohort 103/2,919 3.53% [2.92%, 4.26%]